Skip to content
drillr.ai
Sign up

688016.SH

Shanghai MicroPort Endovascular MedTech Co., Ltd.

SSE · Healthcare · Medical - Devices · CN

CNY 84.10
−0.36%
Ask drillr

  • Oct 30, 2026, 02:12 UTC

    Shanghai MicroPort Endovascular MedTech’s Fishhawk disposable thrombectomy device began its first post-market clinical applications at several hospitals in China.

    Source:

  • Oct 29, 2026, 11:50 UTC

    Shanghai MicroPort Endovascular MedTech reported revenue of RMB 1.119 billion and net profit attributable to shareholders of RMB 449 million for the first three quarters of 2026.

    Source:

  • Oct 29, 2026, 11:50 UTC

    Shanghai MicroPort Endovascular MedTech reported third-quarter 2026 revenue of RMB 325 million, up 8.20% year over year, and net profit attributable to shareholders of RMB 126 million, up 10.31%.

    Source: